133 related articles for article (PubMed ID: 31916733)
1. YOD1 Deubiquitinates NEDD4 Involved in the Hippo Signaling Pathway.
Park JH; Kim SY; Cho HJ; Lee SY; Baek KH
Cell Physiol Biochem; 2020 Jan; 54(1):1-14. PubMed ID: 31916733
[TBL] [Abstract][Full Text] [Related]
2. Synergistic effect of YOD1 and USP21 on the Hippo signaling pathway.
Park SS; Baek KH
Cancer Cell Int; 2023 Sep; 23(1):209. PubMed ID: 37743467
[TBL] [Abstract][Full Text] [Related]
3. Deubiquitinating enzyme YOD1 deubiquitinates and destabilizes α-synuclein.
Park SS; Do HA; Park HB; Choi HS; Baek KH
Biochem Biophys Res Commun; 2023 Feb; 645():124-131. PubMed ID: 36682332
[TBL] [Abstract][Full Text] [Related]
4. Neural precursor cell-expressed, developmentally down-regulated 4 (NEDD4) regulates hydrogen peroxide-induced cell proliferation and death through inhibition of Hippo signaling.
Jeon SA; Kim DW; Cho JY
FASEB J; 2019 Dec; 33(12):14772-14783. PubMed ID: 31690112
[TBL] [Abstract][Full Text] [Related]
5. The SGK3-triggered ubiquitin-proteasome degradation of podocalyxin (PC) and ezrin in podocytes was associated with the stability of the PC/ezrin complex.
Yuan YP; Zhao H; Peng LQ; Li ZF; Liu S; Yuan CY; Mwamunyi MJ; Pearce D; Yao LJ
Cell Death Dis; 2018 Nov; 9(11):1114. PubMed ID: 30385740
[TBL] [Abstract][Full Text] [Related]
6. Deubiquitinase YOD1 potentiates YAP/TAZ activities through enhancing ITCH stability.
Kim Y; Kim W; Song Y; Kim JR; Cho K; Moon H; Ro SW; Seo E; Ryu YM; Myung SJ; Jho EH
Proc Natl Acad Sci U S A; 2017 May; 114(18):4691-4696. PubMed ID: 28416659
[TBL] [Abstract][Full Text] [Related]
7. NEDD4 controls intestinal stem cell homeostasis by regulating the Hippo signalling pathway.
Bae SJ; Kim M; Kim SH; Kwon YE; Lee JH; Kim J; Chung CH; Lee WJ; Seol JH
Nat Commun; 2015 Feb; 6():6314. PubMed ID: 25692647
[TBL] [Abstract][Full Text] [Related]
8. YOD1 attenuates neurogenic proteotoxicity through its deubiquitinating activity.
Tanji K; Mori F; Miki Y; Utsumi J; Sasaki H; Kakita A; Takahashi H; Wakabayashi K
Neurobiol Dis; 2018 Apr; 112():14-23. PubMed ID: 29330040
[TBL] [Abstract][Full Text] [Related]
9. Upregulation of Neural Precursor Cell Expressed Developmentally Downregulated 4-1 is Associated with Poor Prognosis and Chemoresistance in Lung Adenocarcinoma.
Song YH; Zhang CQ; Chen FF; Lin XY
Chin Med J (Engl); 2018 Jan; 131(1):16-24. PubMed ID: 29271375
[TBL] [Abstract][Full Text] [Related]
10. Neddylation-mediated Nedd4-2 activation regulates ubiquitination modification of renal NBCe1.
Tu J; Zhang B; Fang G; Chang W; Zhao Y
Exp Cell Res; 2020 May; 390(2):111958. PubMed ID: 32173470
[TBL] [Abstract][Full Text] [Related]
11. The mechanism of neural precursor cell expressed developmentally down-regulated 4-2 (Nedd4-2)/NEDD4L-catalyzed polyubiquitin chain assembly.
Todaro DR; Augustus-Wallace AC; Klein JM; Haas AL
J Biol Chem; 2017 Nov; 292(47):19521-19536. PubMed ID: 28972136
[TBL] [Abstract][Full Text] [Related]
12. The many substrates and functions of NEDD4-1.
Huang X; Chen J; Cao W; Yang L; Chen Q; He J; Yi Q; Huang H; Zhang E; Cai Z
Cell Death Dis; 2019 Dec; 10(12):904. PubMed ID: 31787758
[TBL] [Abstract][Full Text] [Related]
13. PKC/Nedd4-2 Signaling Pathway Regulates the Cell Surface Expression of Drug Transporter hOAT1.
Xu D; Zhang J; Zhang Q; Fan Y; Liu C; You G
Drug Metab Dispos; 2017 Aug; 45(8):887-895. PubMed ID: 28572241
[TBL] [Abstract][Full Text] [Related]
14. Regulation of PTEN degradation and NEDD4-1 E3 ligase activity by Numb.
Shao C; Li Z; Ahmad N; Liu X
Cell Cycle; 2017 May; 16(10):957-967. PubMed ID: 28437168
[TBL] [Abstract][Full Text] [Related]
15. E3 ubiquitin ligase Nedd4 inhibits AP-1 activity and TNF-α production through targeting p38α for polyubiquitination and subsequent degradation.
Liu Q; Zhang S; Chen G; Zhou H
Sci Rep; 2017 Jul; 7(1):4521. PubMed ID: 28674435
[TBL] [Abstract][Full Text] [Related]
16. NEDD4-induced degradative ubiquitination of phosphatidylinositol 4-phosphate 5-kinase α and its implication in breast cancer cell proliferation.
Tran MH; Seo E; Min S; Nguyen QT; Choi J; Lee UJ; Hong SS; Kang H; Mansukhani A; Jou I; Lee SY
J Cell Mol Med; 2018 Sep; 22(9):4117-4129. PubMed ID: 29851245
[TBL] [Abstract][Full Text] [Related]
17. E3-ubiquitin ligase NEDD4 enhances bone formation by removing TGFβ1-induced pSMAD1 in immature osteoblast.
Jeon SA; Lee JH; Kim DW; Cho JY
Bone; 2018 Nov; 116():248-258. PubMed ID: 30125728
[TBL] [Abstract][Full Text] [Related]
18. NEDD4 promotes cell growth and motility in hepatocellular carcinoma.
Zheng H; Ke X; Li D; Wang Q; Wang J; Liu X; Deng M; Deng X; Xue Y; Zhu Y; Wang Q
Cell Cycle; 2018; 17(6):728-738. PubMed ID: 29480061
[TBL] [Abstract][Full Text] [Related]
19. Auto-ubiquitination of NEDD4-1 Recruits USP13 to Facilitate Autophagy through Deubiquitinating VPS34.
Xie W; Jin S; Wu Y; Xian H; Tian S; Liu DA; Guo Z; Cui J
Cell Rep; 2020 Feb; 30(8):2807-2819.e4. PubMed ID: 32101753
[TBL] [Abstract][Full Text] [Related]
20. NEDD4-2 (neural precursor cell expressed, developmentally down-regulated 4-2) negatively regulates TGF-beta (transforming growth factor-beta) signalling by inducing ubiquitin-mediated degradation of Smad2 and TGF-beta type I receptor.
Kuratomi G; Komuro A; Goto K; Shinozaki M; Miyazawa K; Miyazono K; Imamura T
Biochem J; 2005 Mar; 386(Pt 3):461-70. PubMed ID: 15496141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
